Skip to content

Screener

Eligibility screening

Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Sponsored by AstraZenecaStudy detailsClinicalTrials.gov

86 US sites in AL, AZ, CA, CO +24

Before we begin

Who are you filling this out for?

Your answer affects how the questions are phrased.